We are live on ! Find out more
HHS icon

Harte-Hanks
HHS

23 hedge funds and large institutions have $8.92M invested in Harte-Hanks in 2025 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 2323 (0)

0% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 3

0.05% less ownership

Funds ownership: 30.46%30.42% (-0.05%)

17% less capital invested

Capital invested by funds: $10.8M → $8.92M (-$1.85M)

29% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 7

Holders
23
Holders Change
Holders Change %
0%
% of All Funds
0.3%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
5
Reduced
7
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
JP Morgan Chase
26
JP Morgan Chase
New York
-$53 -11 Closed

HHS Hedge Fund Activity: Q2 2025 in Review

23 of the 7,598 institutional investors tracked by Wall St. Rank reported a position in Harte-Hanks (HHS) for Q2 2025, worth a combined $8.92M — down 17% from $10.8M a quarter earlier.

Fund positioning in HHS was balanced in Q2 2025: 3 funds opened new positions, 3 closed out, 5 added to existing stakes and 7 trimmed.

The largest buyer was UBS Group, opening a new position worth an estimated $217K. The largest seller was Man Group, cutting an estimated $92K.

  • 23 institutional investors held Harte-Hanks (HHS) as of Q2 2025, unchanged from Q1 2025.
  • Funds reported $8.92M of Harte-Hanks stock for Q2 2025, down 17% quarter-over-quarter.
  • 3 funds opened new Harte-Hanks positions in Q2 2025 and 3 closed out, a net change of 0 holders.
  • The largest Harte-Hanks buyer in Q2 2025 was UBS Group, an estimated $217K added.
  • The largest Harte-Hanks seller in Q2 2025 was Man Group, an estimated $92K sold.

Based on aggregated 13F filings for Q2 2025.